Cholangiocarcinoma
Cholangiocarcinoma is a rare cancer that forms in the bile ducts, which are the tubes that carry bile from the liver to the small intestine. Symptoms may include jaundice, abdominal pain, and weight loss.
Advanced Cholangiocarcinoma: Futibatinib Study
We are studying the effects of futibatinib in patients with advanced cholangiocarcinoma with FGFR2 fusions or rearrangements. The goal is to see if it helps improve their condition and to understand its safety.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Do you have a confirmed diagnosis of cholangiocarcinoma (bile duct cancer)?
- Have you received at least one prior treatment with gemcitabine or a platinum-based drug for your cancer?
- Have you had any major surgery in the last 4 weeks?
- Are you currently pregnant or breastfeeding?
- Do you have any serious heart problems, like severe angina or heart failure?
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Azienda Ospedaliero-Universitaria Di Bologna IRCCS Istituto Di Ricerca E Di Cura A Carattere Scientifico
Oncology
Bologna, Italy
Humanitas Research Hospital
Oncology
Rozzano, Italy
Universita' Degli Studi Di Verona
Oncology
Verona, Italy
Sponsor: Taiho Oncology Inc.
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.